ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751620 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751620; 2) Community: the network communities that were significantly associated with the response to NSC 751620; 3) Molecule: the relationships between components within communities and NSC 751620; 4) MDR: the compounds that were significantly associated with the NSC 751620.

NSC Compound Enrichment Correlation
NSC 733503 cis-6-(3-Bromopropyl)-12,13-dihydro-8,9-dimethoxy-3-nitro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0100967765290133 0.31669353
NSC 736802 Null 0.0100967765290133 0.15460261
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0100967765290133 0.28089312
NSC 748712 Null 0.0100967765290133 0.33799304
NSC 100880 Camptothecin 0.0135588245836371 0.19986699
NSC 132313 Dianhydrogalactitol 0.0135588245836371 0.12462964
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0135588245836371 0.083793391
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0135588245836371 0.089810133
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0135588245836371 0.14153622
NSC 643836 Null 0.0135588245836371 0.21467937
Total:53  Current:12    [First] [Prev] [Next] [Last]